Argenica Therapeutics Ltd(AU:AGN)
A$0.12-0.01 (-7.69%)
AU:AGN
Argenica Therapeutics Ltd financials statements
A$0.12
At close:-0.01 (-7.69%)
Want to see AU:AGN full AI Analyst Report?
Argenica Therapeutics Ltd (AGN) Income Statement
14 Followers
Argenica Therapeutics Ltd Income Statement
Last quarter (Q4 2026), Argenica Therapeutics Ltd's total revenue was AU$0.00, a decrease of 100.00% from the same quarter last year. In Q4, Argenica Therapeutics Ltd's net income was AU$2.45M. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 0.00 | AU$ 3.21M | AU$ 2.60M | AU$ 1.75M | AU$ 259.10K | |
| AU$ 0.00 | AU$ 3.21M | AU$ 2.60M | AU$ 1.75M | AU$ 259.10K | |
| AU$ 7.06M | AU$ 10.90M | AU$ 8.27M | AU$ 6.62M | AU$ 4.35M | |
| Depreciation and Amortization | AU$ 0.00 | AU$ 7.68M | AU$ 5.67M | AU$ 4.87M | AU$ 4.09M |
| AU$ -7.06M | AU$ 0.00 | AU$ -1.90M | AU$ -1.32M | AU$ -257.41K | |
| AU$ -7.06M | AU$ -7.68M | AU$ -5.67M | AU$ -6.62M | AU$ -4.09M | |
| AU$ 1.72M | AU$ 512.25K | AU$ -1.90M | AU$ 431.93K | AU$ 1.68K | |
| AU$ -5.34M | AU$ -7.17M | AU$ -7.57M | AU$ -6.19M | AU$ -4.09M | |
| AU$ -1.37M | AU$ -7.17M | AU$ -5.48M | AU$ -4.82M | AU$ -4.09M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.01 | AU$ -0.06 | AU$ -0.05 | AU$ -0.06 | AU$ -0.06 |
| Diluted EPS | AU$ -0.01 | AU$ -0.06 | AU$ -0.05 | AU$ -0.06 | AU$ -0.06 |
| Weighted Average Shares Outstanding | 128.46M | 127.53M | 103.39M | 87.58M | 73.93M |
| Weighted Average Shares Outstanding (Diluted) | 128.46M | 127.53M | 103.71M | 87.58M | 73.93M |
Currency in AUD

